This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Hanger, Inc. Announces Samuel M. Liang To Become President Of Hanger Clinic

Stocks in this article: HGR

AUSTIN, Texas, May 12, 2014 /PRNewswire/ -- Hanger, Inc. (NYSE: HGR) today announced that Samuel M. Liang of Bayer HealthCare will join Hanger and become the President of Hanger Clinic, its largest patient care subsidiary.  Mr. Liang will start as an Executive Vice President at Hanger and work closely with incumbent Hanger Clinic President Richmond L. Taylor until the third quarter 2014, when Mr. Liang will assume the role of President of Hanger Clinic.  At that time, Mr. Taylor will remain an Executive Vice President of Hanger, Inc., continuing to work closely with Mr. Liang to ensure a smooth transition at Hanger Clinic, until his retirement on December 31, 2014.

Samuel M. Liang, Senior Vice President, Bayer HealthCare, Radiology and Interventional

"As former President and CEO of two medical device companies, Sam's proven global leadership in healthcare aligns with Hanger Clinic's continuing growth trajectory," Hanger, Inc. President and CEO Vinit Asar said.  "Having worked with Sam previously, I can attest to his high integrity, strong collaborative style, and operational prowess.  He has built outstanding relationships with physicians, customers and other stakeholders in the medical community.  I am confident Sam will continue to improve on our strong O&P business while injecting new perspectives and driving new prospects."  

Mr. Liang brings 30 years' global cross-functional experience in medical device and pharmaceutical business development and operations.  He will join Hanger from Bayer HealthCare, Radiology & Interventional where he serves as Senior Vice President.  Prior to that role, Mr. Liang served as President and CEO of MEDRAD, Inc., a business of Bayer HealthCare specializing in the development of diagnostic imaging and therapeutic medical devices and services, and of Vascular Therapies, LLC, a vascular device company that created a drug-eluting combination product platform technology.  Mr. Liang also held numerous leadership positions over 24 years at Cordis Corporation, a Johnson & Johnson company. 

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs